In renal cell carcinoma (RCC4) cells, PI3-K/Akt pathway inhibitor (LY294002) largely attenuates the increased HSP70 expression toward heat treatment [33]. This evidence concerns the gene AKT1 and hereditary clear cell renal cell carcinoma.